𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Peripheral reduction of β-amyloid is sufficient to reduce brain β-amyloid: Implications for Alzheimer's disease

✍ Scribed by J. Gregor Sutcliffe; Peter B. Hedlund; Elizabeth A. Thomas; Floyd E. Bloom; Brian S. Hilbush

Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
276 KB
Volume
89
Category
Article
ISSN
0360-4012

No coin nor oath required. For personal study only.

✦ Synopsis

Three loci that modify β-amyloid (Aβ) accumulation and deposition in the brains of a mouse model of Alzheimer's disease have been previously described. One encompasses the Psen2 gene encoding presenilin 2, a component of the γ-secretase activity responsible for generating Aβ by proteolysis. We show that the activity of mouse Psen2, as measured by levels of mRNA accumulation, unexpectedly is heritable in the liver but not the brain, suggesting liver as the origin of brain Aβ deposits. Administration of STI571, a cancer therapeutic that does not cross the blood-brain barrier, reduced accumulation of Aβ in both the blood and the brain, confirming brain Aβ's peripheral origin and suggesting that STI571 and related compounds might have therapeutic/prophylactic value in human Alzheimer's disease. The genes Cib1 and Zfhx1b reside within the other modifier loci and also exhibit heritable expression in the liver, suggesting that they too contribute to Aβ accumulation.

📜 SIMILAR VOLUMES

Microglial interaction with β-amyloid: I
Microglial interaction with β-amyloid: Implications for the pathogenesis of Alzheimer's disease
✍ Maria E. Bamberger; Gary E. Landreth 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB

## Abstract The etiology of Alzheimer's disease (AD) involves a significant inflammatory component as evidenced by the presence of elevated levels of a diverse range of proinflammatory molecules in the AD brain. These inflammatory molecules are produced principally by activated microglia, which are

Cytoplasmic domain of the β-amyloid prot
Cytoplasmic domain of the β-amyloid protein precursor of Alzheimer's disease: Function, regulation of proteolysis, and implications for drug development
✍ Megan L. Kerr; David H. Small 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB 👁 1 views

The ␤-amyloid protein precursor (APP) has been extensively studied for its role in amyloid production and the pathogenesis of Alzheimer's disease (AD). However, little is known about the normal function of APP and its biological interactions. In this Mini-Review, the role of the cytoplasmic domain o